We are Symphony.
We are working to make a difference.
Mission and Goals
Develop small-molecule drug products that address unmet clinical need in ophthalmic, dermal and otic disorders, through utilization of the platform delivery systems, OcuSurf and NanoM Wafer.
Utilize molecules with established safety profiles
Achieve sustained release to obviate frequent dose regimens (NanoM)
Achieve enhanced bioavailability and membrane-permeability (OcuSurf LNP)
Demonstrate proof-of-concept in humans
Products in Development
Early-stage products in ophthalmic, dermal and otic indications, using 505b2 regulatory approaches. Details to be disclosed at a later time.